Association between occupational exposure to arsenic and neurological, respiratory and renal effects

Toxicology and Applied Pharmacology

Volumn 239, Issue 2, 2009, Pages 193-199

  Halatek, Tadeusz ^a   Sinczuk Walczak, Halina ^a   Rabieh, Sasan ^b   Wasowicz, Wojciech ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^b UNIVERSITY OF BAYREUTH   (Germany)

Author keywords

Arsenic; Clara cell protein; Foundry; Kidney; Neurotoxicity

Indexed keywords

ARSENIC; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; COPPER; LEAD; RETINOL BINDING PROTEIN;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EVOKED VISUAL RESPONSE; FOUNDRY; HUMAN; IMMUNOASSAY; INDUSTRIAL WORKER; MALE; NEPHROTOXICITY; NEUROTOXICITY; OCCUPATIONAL EXPOSURE; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RESPIRATORY TRACT DISEASE; SMOKING HABIT; SYMPTOM; WORKPLACE;

ADULT; AIR POLLUTANTS, OCCUPATIONAL; ARSENIC; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, VISUAL; HUMANS; IRON; KIDNEY DISEASES; LEAD; MALE; MASS SPECTROMETRY; MIDDLE AGED; NEUROTOXICITY SYNDROMES; OCCUPATIONAL EXPOSURE; RESPIRATORY TRACT DISEASES; SPIROMETRY; WORKPLACE;

EID: 68949207087     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.04.022     Document Type: Article

References (36)

1. American Conference of Governmental Industrial Hygienists (ACGIH) 2001. Arsenic and soluble inorganic compounds: BEI ®7th edition, Documentation. Publication 7DOC-665
2. American Conference of Governmental Industrial Hygienists (ACGIH) 2005. TLVs and BEIs. 2005. Signature publications. Cincinnati, OH.
3. Arsalane K., Broeckaert F., Knoops B., Clippe A., Buchet J.P., and Bernard A. Increased serum and urinary concentration of lung Clara cell protein in rats acutely exposed to ozone. Toxicol. Appl. Pharmacol. 59 (1999) 169-174
4. Barchowsky A., Klei L.R., Dudek E.J., Swartz H.M., and James P.E. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radic. Biol. Med. 27 (1999) 1405-1412
5. Bernard A. Renal dysfunction induced by cadmium: biomarkers of critical effects. Biometals 17 (2004) 519-523
6. Bernard A., and Lauwerys R. Epidemiological application of early markers of nephrotoxicity. Toxicol. Lett. 46 (1989) 293-306
7. Bernard A., and Lauwerys R. Early markers of cadmium nephrotoxicity: biological significance and predicative value. Toxicol. Environ. Chem. 27 (1990) 65-72
8. Bernard A., Roels H., Buchet J.P., and Lauwerys R. Decrease of serum Clara cell protein in smokers. Lancet 339 (1992) 1620-1621
9. Bernard A., Gonzalaz J.M., Siles E., Trulillano G., and Lauwerys R. Early decrease of serum Clara cell protein in silica-exposed workers. Eur. Respir. J. 7 (1994) 1932-1937
10. Blom S., Lagerkvist B., and Linderholm H. Arsenic exposure to smelter workers. Clinical and neurophysiological studies. Scand. J. Work, Environ. Health 11 (1985) 265-269
11. Brune D., Nordberg G., and Wester P.O. Distribution of 23 elements in the kidney, liver and lungs of workers from a smeltery and refinery in North Sweden exposed to a number of elements and of control group. Sci. Total Environ. 16 (1980) 13-35
12. Chattopadhyay S., Bhaumik S., Purkayastha M., Basu S., Nag Chaudhuri A., and Das Gupta S. Apoptosis and necrosis in developing brain cells due to arsenic toxicity and protection with antioxidants. Toxicol. Lett. 136 (2002) 65-76
13. Crichton R.R., Wilmet S., Legssyer R., and Ward R.J. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J. Inorg. Biochem. 91 (2002) 9-18
14. Doyle I.R., Nichols T.E., and Bersten A.D. Partitioning lung and plasma proteins: circulating surfactant proteins as biomarkers of alveolocapillary permeability. Clin. Exp. Pharm. Physiol. 26 (1999) 185-197
15. Felix K., Manna S.K., Wise K., Barr J., and Ramesh G.T. Low levels of arsenite activates nuclear factor-kappaB and activator protein-1 in immortalized mesencephalic cells. J. Biochem. Mol. Toxicol. 19 (2005) 67-77
16. Gerr F., and Letz R. Epidemiological case definitions of peripheral neuropathy: experience from two neurotoxicity studies. Neurotoxicology 21 (2000) 761-768
17. Hałatek T., and Jakubowski M. Latex-immunological method of determination of micromolecular proteins and albumins in urine. Part 1. Description of the method [in Polish]. Med. Pr. 42 (1991) 77-87
18. Halatek T., Trzcinka-Ochocka M., Matczak M., Krajewska B., Wronska-Nofer T., and Rydzynski K. Studies on the relationship between occupational exposure to manganese and serum Clara cell protein levels in shipyard workers. Trace Elemen. Elyctrolytes 17 (2000) 48-53
19. Halatek T., Sińczuk-Walczak H., and Rydzyński K. Prognostic significance of low level serum Clara cells phospholipid-binding protein in aluminium neurotoxicity. J. Inorg. Biochem. 99 (2005) 1904-1911
20. Halatek T., Sińczuk-Walczak H., Szymczak M., and Rydzynski K. Neurological and respiratory symptoms in shipyard welders exposed to manganese. Int. J. Occup. Environ. Health 18 (2005) 265-274
21. 2-microglobulin as early markers of occupational exposure to nitric oxides. Inhal. Toxicol. 7 (2005) 87-97
22. Halatek T., Sińczuk-Walczak H., and Rydzyński K. Early neurotoxic effects of inhalation exposure to aluminium and/or manganese assessed by serum levels of phospholipid-binding Clara cells protein. J. Environ. Sci. Health Part A 48 (2008) 118-124
23. Järup L., Pershagen G., and Wal S. Cumulative arsenic exposure and lung cancer in smelter workers: a dose-response study. Am. J. Ind. Med. 15 (1989) 31-41
24. Lantz R.C., and Hays A.M. Role of oxidative stress in arsenic-induced toxicity. Drug Metab. Rev. 38 (2006) 791-804
25. Lee-Feldstein A. Cumulative exposure to arsenic and its relationship to respiratory cancer among copper smelter employees. J. Ocup. Med. 28 (1986) 296-302
26. Lesur O., Bernard A., Arsalane K., Lauwerys R., Begin R., Cantin A., and Lane D. Clara cell protein (CC16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. Am. J. Respir. Crit Care Med. 152 (1995) 290-297
27. Prozialeck W.C., Edwards J.R., Nebert D.W., Woods J.M., Barchowsky A., and Atchison W.D. Vascular system as a target of metal toxicity. Toxicol. Sci. 28 (2007) 45-49
28. Roels H.A., Hoet P., and Lison D. Usefulness of biomarkers of exposure to inorganic mercury, lead or cadmium in controlling occupational and environmental risks of nephrotoxicity. Ren. Fail. 21 (1999) 251-262
29. Shijubo N., Itoh Y., Yamaguchi T., Shibuya Y., Morita Y., Hirasawa M., Okutani R., Kawai T., and Abe S. Serum and BAL Clara cell 10 kDa protein (CC 10) levels and CC 10-positive bronchiolar cells are decreased in smokers. Eur. Respir. J. 10 (1997) 1108-1114
30. Sinczuk_Walczak H., Jakubowski M., and Matczak W. Neurological and neurophysiological examination of workers occupationally exposed to manganese. Int. J. Occup. Environ. Health 14 (2001) 329-337
31. Sinczuk-Walczak H., Matczak W., Razniewska G., and Szymczak M. Neurological and neurophysiological examinations of workers occupationally exposed to aluminium. Med. Pracy 56 (2003) 9-17
32. Sinha M., Manna P., and Sil P.C. Arjunolic acid attenuates arsenic-induced nephrotoxicity. Pathophysiology 15 (2008) 147-157
33. Taylor S.A., Chivers I.D., Price R.G., Arce-Tomas M., Milligan P., Francini I., et al. The assessment of biomarkers to detect nephrotoxicity using an integrated database. Environ. Res. 75 (1997) 23-33
34. Triebig G., and Buttner J. Neurotoxic occupational substances: I. Metals and their compounds. A literature review of the years 1970 to1982. Zentralbl. Bakteriol. Mikrobiol. Hyg. [B] 177 (1983) 11-36
35. 2-microglobulin in renal disease. Nephron 10 (1973) 320-331
36. Yamanaka K., Hasegawa A., Sawamura R., and Okada S. Cellular response to oxidative damage in lung induced by the administration of dimethylarsinic acid, a major metabolite of inorganic arsenics, in mice. Toxicol. Appl. Pharmacol. 108 (1991) 205-213